MVM Partners
Old City Hall, 45 School StreetBoston, MA 2108
Firm Size
- Assets Under Management (AUM):$1.1 Billion
- Number of Funds:8
- Employees:
- Firm Type:Venture Capital
- Focus Areas:
Software & Technology
Services
Healthcare
Description
MVM Partners, LLC is an investment management firm based in Boston, Massachusetts. The company specializes in venture capital and private equity investments in the healthcare sector. MVM Partners focuses on funding and supporting innovative companies in areas such as pharmaceuticals, biotechnology, medical devices, and healthcare services. Founded in 1997, MVM Partners has built a strong reputation for its expertise and successful investments in the healthcare industry. The firm takes a long-term approach to investing, partnering with entrepreneurs and management teams to help them achieve their growth objectives. MVM Partners has a diverse portfolio of companies, ranging from early-stage startups to more established firms. They provide financial resources, strategic guidance, and industry expertise to these companies, helping them navigate the complex healthcare landscape and accelerate their growth. With its location in Boston, a hub for the healthcare industry and home to numerous prestigious research institutions and hospitals, MVM Partners is well-positioned to identify and invest in promising healthcare ventures. Their team of experienced professionals combines deep scientific and operational knowledge with financial acumen to make informed investment decisions. Overall, MVM Partners, LLC is a leading investment management firm in Boston, Massachusetts, specializing in venture capital and private equity investments in the healthcare sector. They play a crucial role in supporting and driving the growth of innovative healthcare companies, ultimately contributing to advancements in the field and improving patient outcomes.Latest News
Powered by
Jan 24, 2024: icotec ag raises $30m in growth financing from MVM Partners
icotec ag, the leading company in the field of innovative spinal tumor implants is pleased to announce a significant milestone in its growth journey by establishing a strategic partnership with MVM Partners ("MVM"), a global healthcare venture capital firm. icotec is commercializing groundbreaking BlackArmor® Carbon/PEEK products that may offer significant clinical advantages over traditional metal implants in the context of spine oncology, making the full potential of the treatment possibilities available for patients along their journey.
Sep 27, 2023: BioProtect Secures $28M to Commercialize its Biodegradable Balloon for Rectal Protection During Prostate Cancer Radiation Therapy
BioProtect Ltd, a private Med Tech company focused on providing innovative, biodegradable spacing solutions, announced today the successful close of a $28 million funding. The round was led by MVM Partners, with participation from current investors: Triventures, KB Investments, Peregrine Ventures, Almeda Ventures, and Consensus Business Group of Vincent Tchenguiz. Proceeds from this financing will support US commercialization of the BioProtect Balloon Implant System, which recently received FDA clearance for rectal protection during radiation therapy for prostate cancer.
Jun 13, 2023: LSI USA Emerging Medtech Summit Returns to Dana Point March 18, 2024
LSI, the company behind LSI Emerging Medtech Summits, the partnering events for global leaders building breakthrough healthcare businesses, today announced it will host its next USA Emerging Medtech Summit, LSI USA '24, on March 18 through 22 at the Monarch Beach Resort, Waldorf Astoria in Dana Point, California .